AVANOS MEDICAL, INC. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/234691d7-a4f3-4c6c-84d5-916a8fe4e9ea/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-61.6M | 2025-01-01 – 2025-12-31 | evidence 0001606498-26-000004 |
| FY 2024 | $-396.2M | 2024-01-01 – 2024-12-31 | evidence 0001606498-25-000024 |
| FY 2023 | $4.2M | 2023-01-01 – 2023-12-31 | evidence 0001606498-24-000018 |
| FY 2022 | $35.5M | 2022-01-01 – 2022-12-31 | evidence 0001606498-24-000018 |
| FY 2021 | $-39.0M | 2021-01-01 – 2021-12-31 | evidence 0001606498-24-000018 |
| FY 2020 | $-48.5M | 2020-01-01 – 2020-12-31 | evidence 0001606498-23-000020 |
| FY 2019 | $-55.7M | 2019-01-01 – 2019-12-31 | evidence 0001606498-20-000018 |
| FY 2018 | $500.0k | 2018-01-01 – 2018-12-31 | evidence 0001606498-19-000018 |
| FY 2017 | $-43.1M | 2017-01-01 – 2017-12-31 | evidence 0001606498-18-000016 |
| FY 2016 | $-107.1M | 2016-01-01 – 2016-12-31 | evidence 0001606498-18-000016 |
| FY 2015 | $-135.7M | 2015-01-01 – 2015-12-31 | evidence 0001606498-18-000016 |
| FY 2014 | $94.3M | 2014-01-01 – 2014-12-31 | evidence 0001606498-15-000009 |
| FY 2013 | $225.3M | 2013-01-01 – 2013-12-31 | evidence 0001606498-15-000009 |
| FY 2012 | $228.0M | 2012-01-01 – 2012-12-31 | evidence 0001606498-15-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).